| Index | Recent Threads | Unanswered Threads | Who's Active | Guidelines | Search |
 |
World Community Grid Forums
Category: Community
Forum: Chat Room
Thread: Interesting Medical News (Non-WCG Related Projects) |
| No member browsing this thread |
|
Thread Status: Active Total posts in this thread: 377
|
|
| Author |
|
|
Dataman
Ace Cruncher Joined: Nov 16, 2004 Post Count: 4865 Status: Offline Project Badges: 
|
The dark side of drug research ... Money.
----------------------------------------"If approved, Pharmacyclics plans to charge $125,000 a year for Ibrutinib, which sounds exorbitant but is actually pretty standard for these revolutionary cancer treatments." http://finance.yahoo.com/news/cramer-biggest-...-drug-ages-222417559.html   |
||
|
|
alged
Master Cruncher FRANCE Joined: Jun 12, 2009 Post Count: 2360 Status: Offline Project Badges: 
|
At France's Institut Louis Pasteur and INSERM teams of biologists have just targeted 3 critical proteins involved in HIV replication process that can be muted to stop the mecanism used by the virus.
----------------------------------------You can find the notice (in french) here: HIV: new therapeutic targets cheers  |
||
|
|
alged
Master Cruncher FRANCE Joined: Jun 12, 2009 Post Count: 2360 Status: Offline Project Badges:
|
In august was held the 2013 Annual Meeting ASCO (American Society of Clinical Oncology)
----------------------------------------One of the main topic was new ways to treat cancer thru own patient's immune system:here a good summary of these new techniques of immunotherapy was given:here This article is in french newspaper Le Figaro but i think many WCG crunches read french (i know...) others can refer to the ASCO site cheers |
||
|
|
[CSF] Thomas Dupont
Veteran Cruncher Joined: Aug 25, 2013 Post Count: 685 Status: Offline |
In august was held the 2013 Annual Meeting ASCO (American Society of Clinical Oncology) One of the main topic was new ways to treat cancer thru own patient's immune system:here a good summary of these new techniques of immunotherapy was given:here This article is in french newspaper Le Figaro but i think many WCG crunches read french (i know...) others can refer to the ASCO site cheers Merci beaucoup pour cet article alged !  |
||
|
|
alged
Master Cruncher FRANCE Joined: Jun 12, 2009 Post Count: 2360 Status: Offline Project Badges:
|
Have you heard abt Particle Therapy or Hadrontherapy
----------------------------------------a new center to treat cancers with that technique is due to open in France here the link in Le Figaro ( in french ): Les ions carbone, nouvelle arme contre le cancer good read and crunching |
||
|
|
littlepeaks
Veteran Cruncher USA Joined: Apr 28, 2007 Post Count: 748 Status: Offline Project Badges: 
|
This isn't the latest medical news, but it's news to me and probably news and of interest to most of you fellow crunchers, as well.
I just retired my second (and hopefully last) time last summer. Having been involved in some research, I thought it might be neat to participate in a medical clinical trial. I tried to find a list of medical trials in this area, and came up with the site Center Watch. Among other things, this site lists on-going clinical trials going on by location, and then by medical condition. (Appears to be U.S. only) For those interested, it also lists new drugs in research, and FDA drug approvals. Unfortunately for me, I'm 66 years old, and most studies end at 65. Also, fortunately for me, I don't seem to have much wrong with me (yet) that they seem to be interested studying. There is a lot of information on this web site, and think it may be interesting and useful to all. BTW, Happy New Year everyone. --lp |
||
|
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
Not that it is anything new adding to what is wanted to be done with insulin, blood sugar level reactiveness, but it is making progress: http://www.bbc.com/news/health-31291722 coining it as 'smart' insulin.
Of course, the intelligent insulin pump already exists, tests blood at intervals and gives a bolus if mm/mol mg/dl levels are too high. |
||
|
|
twilyth
Master Cruncher US Joined: Mar 30, 2007 Post Count: 2130 Status: Offline Project Badges: 
|
This past week the first comprehensive epigenomics map was published.
----------------------------------------The epigenome consists of the various ways that DNA is modified by chemical tags attached to the sugar backbone of double stranded DNA. It's call the 'epi' (greek for 'above') genome because these tags don't change the coding of the base nucleotides - C, G, A and T. Rather, the helix structure is marked while the base pairs aren't affected. One of the many things that's interesting about the epigenome is the fact that in some cases, these markers can be inherited. And since the marks are strongly influenced by things like environment, toxins, diet, etc., it seems to be doing an end run around traditional notions of evolution. Here's the article And here's a short page on what the epigenome is.   |
||
|
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
It's a 'modern' problem in hospitals and other treatment centres... MRSA. And old eyesore cure seems to remedy this: Garlic+Onion+Cow stomach salts
http://www.bbc.com/news/uk-england-nottinghamshire-32117815. Of course the 25ml of English wine as constituent will be something hard to come by :D |
||
|
|
twilyth
Master Cruncher US Joined: Mar 30, 2007 Post Count: 2130 Status: Offline Project Badges:
|
Experimental cancer drug repurposed to treat Alzheimers And more drugs that have already made it part way through the regulatory process could be found to have valuable therapeutic effects for diseases other than what they were designed to treat.
----------------------------------------Scientists have found that a compound originally developed as a cancer therapy potentially could be used to treat Alzheimer’s disease. The team demonstrated that the drug, saracatinib, restores memory loss and reverses brain problems in mouse models of Alzheimer’s, and now the researchers are testing saracatinib’s effectiveness in humans. The study was funded by the National Institutes of Health as part of an innovative crowdsourcing initiative to repurpose experimental drugs. Clinical trials are starting so if you know someone who might benefit, spread the word. |
||
|
|
|